Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
BABA DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds
4+ week, 1+ day ago (192+ words) NEW YORK CITY, NY / ACCESS Newswire / August 14, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Alibaba Group Holding Limited (NYSE:BABA) and certain of its officers. The Complaint…...
WIX INVESTOR DEADLINE: Wix.com Ltd. Investors with Substantial Losses Have Opportunity to Lead the Wix Class Action Lawsuit - September 22, 2026 Deadline
2+ week, 5+ day ago (98+ words) San Diego, California--(Newsfile Corp. - August 24, 2026) - The law firm of Robbins Geller Rudman & Dowd LLP announces......
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Peabody Energy Investors of Securities Class Action Lawsuit Deadline on August 24, 2026
4+ week, 11+ hour ago (268+ words) in Peabody Energy between October 14, 2024 and May 4, 2026 and would like to discuss your legal rights,...
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Peabody Energy Investors of Securities Class Action Lawsuit Deadline on August 24, 2026 - AOL
2+ week, 5+ day ago (280+ words) Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Peabody Energy Corporation (“Peabody Energy” or the “Company”) (NYSE: BTU) and reminds investors of the August 24, 2026 deadline to seek the role of lead plaintiff in a…...
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Peabody Energy Investors of Securities Class Action Lawsuit Deadline on August 24, 2026
2+ week, 5+ day ago (299+ words) in Peabody Energy between October 14, 2024 and May 4, 2026 and would like to discuss your legal rights,...
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 13, 2026 in The Simply Good Foods Company Lawsuit - SMPL
3+ day, 18+ hour ago (646+ words) NEW YORK, Sept. 9, 2026 A securities class action alleges Simply Good Foods' former CEO Geoff E. Tanner and CFOs Shaun P. Mara and Christopher J. Bealer certified filings that painted the $280 million OWYN integration as on track, while SMPL shareholders absorbed a decline of…...
Lincoln Pharma sets September 11 record date for 32nd AGM
2+ week, 1+ day ago (534+ words) Lincoln Pharmaceuticals has announced the record date for its 32nd Annual General Meeting. The company will hold the meeting on September 30, 2026, via video conferencing or other audio-visual means. The record date is set for Friday, September 11, 2026. The book closure period runs…...
CCOI INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Cogent Communications Holdings, Inc. and Announces that Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - September 21, 2026 Deadline
1+ week, 6+ day ago (20+ words) San Diego, California--(Newsfile Corp. - August 31, 2026) - The law firm of Robbins Geller Rudman & Dowd LLP announces......
AVEX EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds AEVEX Investors of Securities Class Action Lawsuit Deadline on October 20, 2026 - AOL
2+ week, 4+ day ago (361+ words) Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against AEVEX Corp. ("“AEVEX” or the “Company”) (NYSE: AVEX) and reminds investors of the October 20, 2026 deadline to seek the role of lead plaintiff in a federal securities…...
Levi & Korsinsky Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 14, 2026 - REGN
3+ day, 20+ hour ago (518+ words) NEW YORK, Sept. 9, 2026 Institutional investors with REGN positions may need to assess alleged clinical-trial disclosure failures that preceded a $102.09 per-share decline from the Class Period high. This notice focuses on fiduciary review, portfolio loss documentation, and lead plaintiff considerations. REGN…...